Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch
JavaScript is disabled for your browser. Some features of this site may not work without it.
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch
Objectives: The aim of the study was to evaluate HIV-1 viral load (VL) and inflammatory markers in cerebrospinal fluid (CSF) and neurocognitive performance in patients with neurocognitive impairment (NCI) while they were receiving tenofovir (TDF)/ emtricitabine (FTC)/efavirenz (EFV) and after switching to a regimen with enhanced ...»»»»
(c) Wiley [The definitive version is available at www3.interscience.wiley.com]
Citació Bibliogràfica:
Tiraboschi, J. M., Muñoz-Moreno, J. A., Puertas, M. C., Alonso-Villaverde, C., Prats, A., Ferrer, E., et al. (2015). Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch. HIV Medicine, 16(6), 388-392.